このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Usability of the FTEXES Wearable Textile Platform for Functional Electrical Stimulation and EMG (FTEXES)

2026年11月2日 更新者:Giuseppe Andreoni、Politecnico di Milano

Interventional Clinical Trial Evaluating the Usability of the FTEXES System (Functionalized TEXtiles for Electrical Stimulation), a Wearable Textile-Based Platform for Functional Electrical Stimulation and Surface Electromyography

FTEXES (Functionalized TEXtiles for Electrical Stimulation) is a wearable platform based on sensorized garments (Smart Pants and Smart T-shirt) with integrated textile electrodes for surface electromyography (EMG) recording and functional electrical stimulation (FES). This single-center, open-label, non-randomized study evaluates the usability of the system in a controlled laboratory setting. Fifteen participants (5 healthy adults, 5 patients with neuromotor disability, 5 healthcare professionals) take part in a single 45-60 minute session including donning, system setup, calibration, functional tasks (gait for the lower limb; reaching and grasping for the upper limb), doffing and skin inspection. Comfort, skin tolerability, stimulation-related discomfort, perceived usability, satisfaction and acceptability are assessed with standardized questionnaires. The quality of EMG signals recorded with textile electrodes is evaluated as a secondary objective. The study has no therapeutic purpose for individual participants.

調査の概要

状態

まだ募集していません

研究の種類

介入

入学 (推定)

15

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

    • Lecco
      • Bosisio Parini、Lecco、イタリア、23842
        • IRCCS Eugenio Medea - Associazione La Nostra Famiglia

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

12年歳以上 (子、大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Healthy adults: age 18 years or older; no neuromotor disability; written informed consent.
  • Patients: age 18 years or older, or 12-17 years with parental/guardian consent and minor's assent; neuromotor disability compatible with the use of the FTEXES system; indication for FES confirmed by a physiatrist. Previous FES experience is not required.
  • Healthcare professionals: professional qualification consistent with study activities (physiotherapist or physiatrist).

Exclusion Criteria:

  • Missing informed consent (for minors: missing parental/guardian consent and/or minor's assent).
  • Inability to understand study aims and procedures or to follow instructions.
  • Clinical, functional, cognitive, behavioral or skin conditions that make participation unsafe or inappropriate, in the investigator's judgment.
  • Skin lesions, abrasions, dermatitis, irritation, infection or other dermatological conditions in device contact areas.
  • Healthy adults: known neuromuscular disease, recent trauma, direct involvement in FTEXES development, or professional/academic dependency on the Principal Investigator.
  • Patients: absence of motor disability compatible with the FTEXES system, or no indication for / unsuitability to FES in the physiatrist's judgment.
  • Healthcare professionals: lack of professional qualification or of competence in the use/configuration of FES systems.
  • Any other condition that, in the investigator's judgment, may interfere with study conduct or endpoint assessment.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:非ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Healthy adults

Five adults aged 18 years or older without neuromotor disability use the FTEXES system in a single session.

Sensorized textile garments (Smart Pants for the lower limb, Smart T-shirt for the upper limb) with integrated textile electrodes, connected to a CE-marked FES stimulator (HASOMED RehaMove3) and a CE-marked surface EMG system (FreeEMG 1000). Single session of about 45-60 minutes: donning, setup, calibration, functional tasks (gait cycle or reaching/grasping), doffing and skin inspection.

実験的:Patients with neuromotor disability

Five patients aged 12 years or older with neuromotor disability compatible with FES, as assessed by a physiatrist, use the FTEXES system in a single session.

Sensorized textile garments (Smart Pants for the lower limb, Smart T-shirt for the upper limb) with integrated textile electrodes, connected to a CE-marked FES stimulator (HASOMED RehaMove3) and a CE-marked surface EMG system (FreeEMG 1000). Single session of about 45-60 minutes: donning, setup, calibration, functional tasks (gait cycle or reaching/grasping), doffing and skin inspection.

他の:Healthcare professionals

Five healthcare professionals (3 physiotherapists, 2 physiatrists) configure and operate the FTEXES system and evaluate its usability from the operator's perspective.

Sensorized textile garments (Smart Pants for the lower limb, Smart T-shirt for the upper limb) with integrated textile electrodes, connected to a CE-marked FES stimulator (HASOMED RehaMove3) and a CE-marked surface EMG system (FreeEMG 1000). Single session of about 45-60 minutes: donning, setup, calibration, functional tasks (gait cycle or reaching/grasping), doffing and skin inspection.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Perceived usability: System Usability Scale (SUS) score
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

SUS is a 10-item questionnaire scored from 0 to 100; higher scores indicate better perceived usability.

During and at the end of the single experimental session (approximately 60 minutes)
Wearable comfort: Comfort Rating Scale (CRS) score
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Comfort of the textile garments and textile electrodes assessed with the Comfort Rating Scale (CRS); higher scores indicate greater discomfort.

During and at the end of the single experimental session (approximately 60 minutes)
Stimulation-related pain/discomfort (NRS/VAS 0-10)
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Global and localized discomfort, perceived fatigue and pain associated with functional electrical stimulation, rated on a 0-10 numeric/visual analogue scale; 0 = none, 10 = worst imaginable.

During and at the end of the single experimental session (approximately 60 minutes)
Satisfaction with the assistive device: adapted QUEST 2.0
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Satisfaction with the FTEXES system assessed with an adapted version of the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0); items scored 1-5, higher scores indicate greater satisfaction.

During and at the end of the single experimental session (approximately 60 minutes)
Acceptability and intention to use: Net Promoter Score (NPS) and intention-to-use questionnaire
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Likelihood to recommend the system (NPS, 0-10 rating, summarized as -100 to +100) and intention to use the platform in the future, including at home.

During and at the end of the single experimental session (approximately 60 minutes)

二次結果の測定

結果測定
メジャーの説明
時間枠
Coherence score (0.0-1.0) of EMG signal quality: amplitude and frequency spectrum
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Coherence score (0.0 if signal amplitude <50% of amplitude with standard Ag/AgCl electrodes -1.0 = signal amplitude = 100% of amplitude with standard Ag/AgCl electrodes) of Amplitude and frequency spectrum (% coveragle of signal spectrum) of surface EMG signals recorded with the textile electrodes of the FTEXES garments.

During and at the end of the single experimental session (approximately 60 minutes)
FES artifact rejection in EMG signals
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Effectiveness of rejection of functional electrical stimulation artifacts in surface EMG signals recorded during stimulation scored as number number of artifacts recorded as number of artifacts out of 10 test events.

During and at the end of the single experimental session (approximately 60 minutes)

その他の成果指標

結果測定
メジャーの説明
時間枠
Skin tolerability: visual skin inspection
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Presence of redness, pressure marks, abrasions or other skin reactions in device contact areas, assessed by visual inspection at the end of the session.

During and at the end of the single experimental session (approximately 60 minutes)
Number of participants with adverse events
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Adverse events recorded during the session using the study adverse event form.

During and at the end of the single experimental session (approximately 60 minutes)
Donning and setup performance
時間枠:During and at the end of the single experimental session (approximately 60 minutes)

Time to don/doff the garments and connect/configure the system, level of assistance required and number of non-critical procedural errors, assessed by observation.

During and at the end of the single experimental session (approximately 60 minutes)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Leonardo Boccuni, PhD、IRCCS Eugenio Medea
  • スタディチェア:Giuseppe Andreoni、Politecnico di Milano

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年10月26日

一次修了 (推定)

2026年11月30日

研究の完了 (推定)

2026年12月31日

試験登録日

最初に提出

2026年10月22日

QC基準を満たした最初の提出物

2026年11月2日

最初の投稿 (実際)

2026年11月6日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月6日

QC基準を満たした最後の更新が送信されました

2026年11月2日

最終確認日

2026年10月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 380-26
  • CUP B53C22006960001 (その他の助成金/資金番号:Italian Ministry of University and Research - PNC Fit4MedRob (PNC0000007))
  • L2-648 (その他の識別子:Comitato Etico Territoriale Lombardia 2)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する